DebtVsGrowth
-
Stop Letting Jim Cramer Trade Your Portfolio for You
Jim Cramer can move a stock with a sentence. The real question is whether you should let him move your portfolio. Two of his recent names — Marvell Technology (MRVL) and Bausch Health (BHC) — sit on opposite ends of the risk spectrum. One is riding the AI infrastructure wave. The other is still wrestling…
-
Stop Treating Marvell and Bausch Like the Same Trade
Follow or Fade? Trading Marvell and Bausch After Cramer’s Buy Calls When Jim Cramer pounds the table, do you grab a seat—or head for the exit? That’s the question with Marvell (MRVL) and Bausch Health (BHC). One is riding the AI chip wave with real numbers to back it up. The other is grinding through…
-
Cramer’s Buy Calls Aren’t Alpha — They’re Exit Liquidity
Jim Cramer says buy Marvell and Bausch Health. The real question isn’t whether he’s bullish — it’s whether you should be. Because in 2024, a Cramer buy call isn’t just a recommendation. For some traders, it’s a contrarian indicator. Let’s break this down. Marvell (MRVL): AI Tailwinds — But You’re Paying for Them Marvell is…
You must be logged in to post a comment.